apalutamide for high-risk prostate cancer | learn about clinical trials
Published 4 years ago • 6.9K plays • Length 4:23Download video MP4
Download video MP3
Similar videos
-
4:42
androgen annihilation in high-risk biochemically relapsed prostate cancer | learn clinical trials
-
3:28
apalutamide and the titan clinical trial
-
11:57
#prostatecancer clinical trials: the benefits and risks | #markscholzmd #pcri
-
3:48
olaparib zytiga for metastatic castrate-resistant prostate cancer | learn about clinical trials
-
5:14
olaparib and keytruda for advanced prostate cancer | | learn about clinical trials
-
6:12
apalutamide, adt improve outcomes in high-risk prostate cancer post-surgery
-
6:16
all about clinical trials for advanced prostate cancer (royal) | prostate cancer staging guide
-
2:29
update: fda approves apalutamide (erleada) for metastatic castration-sensitive prostate cancer
-
3:43
startar: adt apalutamide rt docetaxel for psa-recurrent prostate cancer following rp
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
1:28
apalutamide plus adt leads to survival benefit in mcspc
-
6:42
titan trial
-
5:50
unorthodox treatments for high-risk prostate cancer | prostate cancer staging guide
-
5:32
understanding treatment for high-risk prostate cancer | prostate cancer staging guide
-
28:31
prostate cancer highlights from esmo 2022
-
0:54
apalutamide combination is well tolerated in metastatic castration-sensitive prostate cancer
-
8:10
an introduction to clinical trials - 2021 prostate cancer patient conference
-
35:31
m0 space and the spartan trial
-
0:57
dr. morris on os data with apalutamide in prostate cancer